LL-37 is a human-derived antimicrobial peptide that acts as a potent, broad-spectrum “natural antibiotic” and immune modulator. Key benefits include destroying bacteria (including antibiotic-resistant strains), fungi, and viruses; reducing chronic inflammation; accelerating wound healing; and breaking down biofilms.
Core Benefits of LL-37 Peptide:
- Broad-Spectrum Antimicrobial Activity: LL-37 kills Gram-positive and Gram-negative bacteria, viruses, and fungi by permeabilizing their cell membranes.
- Biofilm Disruption: It disrupts biofilms, which are protective layers that bacteria use to evade antibiotics, making it effective against chronic infections.
- Immune Modulation: The peptide regulates the immune system, acting as both pro-inflammatory (to fight infection) and anti-inflammatory (to prevent excess tissue damage).
- Wound Healing & Tissue Repair: It promotes angiogenesis (new blood vessel formation) and wound repair, demonstrated by significant reductions in the size of chronic ulcers.
- Skin Condition Management: It is effective against inflammatory skin conditions such as acne and eczema.
- Potential Antiviral Effects: LL-37 shows promise in blocking viral entry, including SARS-CoV-2, by binding to receptors.
- Metabolic & Neuro-Support: Evidence suggests it can assist in Type 2 diabetes by promoting insulin release and inhibiting amyloid aggregation associated with neurological damage.
LL-37 is used in research and clinical settings, often applied topically or injected subcutaneously for localized infection and wound management
